A functional SNP rs1892901 in FOSL1 is associated with gastric cancer in Chinese population

[1]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[2]  L. Wessels,et al.  Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival , 2015, Oncotarget.

[3]  Z. Zeng,et al.  Fra-1 is upregulated in gastric cancer tissues and affects the PI3K/Akt and p53 signaling pathway in gastric cancer. , 2015, International journal of oncology.

[4]  Hongbing Shen,et al.  Genetic Variation in the 3'-Untranslated Region of NBN Gene Is Associated with Gastric Cancer Risk in a Chinese Population , 2015, PloS one.

[5]  Xiangyi Zheng,et al.  MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells , 2015, Journal of Translational Medicine.

[6]  Yong Xia,et al.  Chrysin Inhibits Tumor Promoter-Induced MMP-9 Expression by Blocking AP-1 via Suppression of ERK and JNK Pathways in Gastric Cancer Cells , 2015, PloS one.

[7]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[8]  I. Haviv,et al.  Widespread FRA1-Dependent Control of Mesenchymal Transdifferentiation Programs in Colorectal Cancer Cells , 2014, PloS one.

[9]  Jian-ming Wang,et al.  TGFBR1 tagging SNPs and gastric cancer susceptibility: A two‐stage case–control study in chinese population , 2014, Molecular carcinogenesis.

[10]  Min Sung Kim,et al.  Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability. , 2013, Human pathology.

[11]  M. Yan,et al.  EGR1 is critical for gastrin‐dependent upregulation of anion exchanger 2 in gastric cancer cells , 2013, The FEBS journal.

[12]  D. Stupack,et al.  Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy. , 2012, Cancer research.

[13]  H. Matsubara,et al.  The molecular role of Fra‐1 and its prognostic significance in human esophageal squamous cell carcinoma , 2012, Cancer.

[14]  Kai-Fu Tang,et al.  MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. , 2012, Carcinogenesis.

[15]  J. Wen,et al.  Activator protein-1 involvement in proliferation inhibition by gene silencing of Twist in gastric cancer cells , 2011, Pathology.

[16]  Wen Tan,et al.  A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1 , 2011, Nature Genetics.

[17]  N. Yoo,et al.  Genetic and expressional alterations of CHD genes in gastric and colorectal cancers , 2011, Histopathology.

[18]  M. Brentani,et al.  Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma , 2011, Histopathology.

[19]  Jack A. Taylor,et al.  SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies , 2009, Nucleic Acids Res..

[20]  S. Reddy,et al.  FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. , 2007, Cancer research.

[21]  N. Colburn,et al.  Fra-1 a target for cancer prevention or intervention. , 2006, Gene.

[22]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Karin Milde-Langosch,et al.  The Fos family of transcription factors and their role in tumourigenesis. , 2005, European journal of cancer.

[24]  K. Belguise,et al.  FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells , 2005, Oncogene.

[25]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[26]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[27]  M. Karin,et al.  AP-1 in cell proliferation and survival , 2001, Oncogene.

[28]  M. Yaniv,et al.  Transformation by ras modifies AP1 composition and activity , 1997, Oncogene.

[29]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[30]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[31]  H. Pehamberger,et al.  Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters. , 2006, European journal of gynaecological oncology.

[32]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[33]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .